IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management III, LLC

Q4 2019 Holdings

Filed 2020-02-14 | 10 holdings | $2.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$1.9M13,92291.6%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$56.8K2,350,4772.7%
Immunomedics, Inc.(IMMU)COM452907108$37.0K1,750,0001.8%
Myokardia, Inc.COM62857M105$23.8K326,4821.1%
Epizyme, Inc.(EPZMEUR)COM29428V104$16.9K687,4270.8%
Audentes Therapeutics, Inc.(BOLDEUR)COM05070R104$13.9K233,0670.7%
Acceleron Pharma Inc.(XLRN)COM00434H108$13.5K254,9230.6%
Natera, Inc.(NTRA)COM632307104$7.0K208,7680.3%
Replimune Group, Inc.(REPL)COM76029N106$4.5K313,9220.2%
CymaBay Therapeutics, Inc.(CBAYUSD)COM23257D103$2.9K1,504,7100.1%